NOVONORM

This brand name is authorized in Austria, Croatia, Cyprus, Estonia, France, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Singapore, Spain, Tunisia.

Active ingredients

The drug NOVONORM contains one active pharmaceutical ingredient (API):

1	Repaglinide UNII 668Z8C33LU - REPAGLINIDE
	Repaglinide is a short-acting oral secretagogue. Repaglinide lowers the blood glucose levels acutely by stimulating the release of insulin from the pancreas, an effect dependent upon functioning β-cells in the pancreatic islets.
	Read more about Repaglinide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BX02	Repaglinide	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BX Other blood glucose lowering drugs, excl. insulins
Discover more medicines within A10BX02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1039171, 1039182, 1044638, 1065204, 1065259, 1065260, 1214536, 1214558, 1214570, 1214581, 1214592, 1214604, 1304862, 1304873, 1304884
ES	Centro de información online de medicamentos de la AEMPS	98076005, 98076012, 98076019
FR	Base de données publique des médicaments	62522076, 63576333, 67364819
HK	Department of Health Drug Office	44796, 44797, 44812
IE	Health Products Regulatory Authority	76407, 76453, 76474, 76497
IL	מִשְׂרַד הַבְּרִיאוּת	3808, 3809, 3810
IT	Agenzia del Farmaco	034162053, 034162127, 034162192, 042114013, 042114025, 043987015, 044421016, 044421028
LT	Valstybinė vaistų kontrolės tarnyba	1004266, 1004267, 1004268, 1006525, 1008354, 1008355, 1029889, 1029891, 1029892, 1029894, 1029895, 1029897
NL	Z-Index G-Standaard, PRK	50911, 50938, 50946
PL	Rejestru Produktów Leczniczych	100000652, 100082740, 100083715
SG	Health Sciences Authority	10672P, 10673P, 10674P
TN	Direction de la Pharmacie et du Médicament	5993061, 5993062, 5993063, 5993064, 5993065, 5993066